Drug patents have expiration dates, after which generic versions of medications can become available. The specific drugs whose patents expire on any given day can vary due to factors like patent extensions, new patent filings, and legal challenges.
When do drug patents typically expire?
The standard patent term for a drug in the United States is 20 years from the filing date of the patent application. However, this period can be extended through mechanisms like the Patent Term Restoration Act (PTRA), which can add back time lost during the FDA's regulatory review process. New patents can also be filed for different aspects of a drug, such as new formulations, manufacturing processes, or methods of use, potentially extending market exclusivity beyond the initial patent expiry [1].
How can I find out which specific patents are expiring soon?
Information on upcoming patent expirations is often tracked by specialized databases. For instance, DrugPatentWatch.com provides data on drug patents, including their expiration dates and the status of generic and biosimilar competition [2]. This type of resource can detail which specific patents are nearing expiry for particular drugs.
What happens after a drug patent expires?
Once a drug patent expires, it can open the door for generic manufacturers to seek approval from regulatory bodies like the U.S. Food and Drug Administration (FDA) to market their own versions of the drug. Generic drugs are typically bioequivalent to their brand-name counterparts and are usually sold at a lower price, increasing patient access and reducing healthcare costs [1]. For biologics, the equivalent of generics are called biosimilars, and their pathway to market approval is also governed by patent expiry and regulatory review [3].